STOCK TITAN

CTS Corporation (CTS) Financials

CTS
Trailing 12 months to March 31, 2026
Revenue $554.8M +7.8% YoY
Net Income $69.1M +19.8% YoY
EPS (Diluted) $2.34 +23.8% YoY
Free Cash Flow $87.6M +14.7% YoY
Market Cap $1.6B as of Oct 10, 2026
Price / Sales 2.9x on $554.8M revenue, trailing 12 months to March 31, 2026
Price / Earnings 23.6x on $69.1M net income, trailing 12 months to March 31, 2026
Price / Book 2.9x on $557.5M equity, Q1 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed Apr 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CTS SEC filings page.

CTS Corporation (CTS) reported $554.8M in revenue over the twelve months to Mar 31, 2026, up 7.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CTS FY2025

CTS converts modest sales growth into faster profit growth, while disciplined leverage and shareholder distributions shape its capital allocation.

In FY2025, net income grew 17.7% while operating cash flow increased only 4.0%, lowering cash conversion from 1.8x to 1.6x. Cash generation still exceeded reported profit, but the gap narrowed, so earnings improved faster than the operating cash they produced.

Revenue increased 5.2%, yet gross profit rose 10.9% and operating income rose 16.1%; gross margin expanded from 36.4% to 38.4%. This pattern indicates margin expansion and operating leverage, not merely more volume.

Buybacks reduced shares outstanding from 30.0M to 28.7M, helping earnings per share rise faster than net income. At the same time, the debt-to-equity ratio fell from 0.4x to 0.4x on higher equity and lower liabilities, while the current ratio remained above 2.0x.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 67 / 100
Financial Health Score 67/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of CTS Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
83

CTS Corporation has an operating margin of 15.3%, meaning the company retains $15 of operating profit per $100 of revenue. This strong profitability earns a score of 83/100, reflecting efficient cost management and pricing power. This is up from 13.8% the prior year.

Growth
28

CTS Corporation's revenue grew 5.2% year-over-year to $541.3M, a solid pace of expansion. This earns a growth score of 28/100.

Leverage
65

CTS Corporation carries a low D/E ratio of 0.39, meaning only $0.39 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 65/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
66

With a current ratio of 2.30, CTS Corporation holds $2.30 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 66/100.

Cash Flow
79

CTS Corporation converts 16.0% of revenue into free cash flow ($86.4M). This strong cash generation earns a score of 79/100.

Returns
79

CTS Corporation earns a strong 11.8% return on equity (ROE), meaning it generates $12 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 79/100. This is up from 10.5% the prior year.

Altman Z-Score Safe
7.21

CTS Corporation scores 7.21, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.6B) relative to total liabilities ($212.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
7/8

CTS Corporation passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.56x

For every $1 of reported earnings, CTS Corporation generates $1.56 in operating cash flow ($102.1M OCF vs $65.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
19.18x

CTS Corporation earns $19.18 in operating income for every $1 of interest expense ($82.6M vs $4.3M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$139.2M
YoY+10.7%
QoQ+1.4%
5Y CAGR+1.6%
10Y CAGR+3.7%

CTS Corporation generated $139.2M in revenue in Q1 2026. This represents an increase of 10.7% from the same quarter a year earlier. Against the prior quarter it is up 1.4%.

EBITDA
$30.8M
YoY+24.3%
QoQ-1.8%
5Y CAGR+4.0%
10Y CAGR+6.5%

CTS Corporation's EBITDA was $30.8M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 24.3% from the same quarter a year earlier. Against the prior quarter it is down 1.8%.

Net Income
$17.2M
YoY+28.7%
QoQ-12.9%
5Y CAGR+7.5%
10Y CAGR+8.1%

CTS Corporation reported $17.2M in net income in Q1 2026. This represents an increase of 28.7% from the same quarter a year earlier. Against the prior quarter it is down 12.9%.

EPS (Diluted)
$0.59
YoY+34.1%
QoQ-11.9%
5Y CAGR+9.8%
10Y CAGR+9.4%

CTS Corporation earned $0.59 per diluted share (EPS) in Q1 2026. This represents an increase of 34.1% from the same quarter a year earlier. Against the prior quarter it is down 11.9%.

Cash & Balance Sheet

Free Cash Flow
$12.3M
YoY+11.3%
QoQ-52.7%
5Y CAGR-7.8%

CTS Corporation generated $12.3M in free cash flow in Q1 2026, representing cash available after capex. This represents an increase of 11.3% from the same quarter a year earlier. Against the prior quarter it is down 52.7%.

Cash & Debt
$90.9M
YoY+0.6%
QoQ+10.4%
5Y CAGR-2.6%
10Y CAGR-3.6%

CTS Corporation held $90.9M in cash as of Q1 2026; long-term debt is not reported for that period.

Dividends Per Share
$0.04
YoY0.0%
QoQ0.0%
5Y CAGR0.0%
10Y CAGR0.0%

CTS Corporation paid $0.04 per share in dividends in Q1 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
29M
YoY-4.2%
QoQ-0.4%
5Y CAGR-2.4%
10Y CAGR-1.4%

CTS Corporation had 29M shares outstanding in Q1 2026. This represents a decrease of 4.2% from the same quarter a year earlier. Against the prior quarter it is down 0.4%.

Margins & Returns

Gross Margin
39.5%
YoY+2.5pp
QoQ+0.4pp
5Y change+6.3pp
10Y change+4.9pp

CTS Corporation's gross margin was 39.5% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.4 percentage points.

Operating Margin
15.8%
YoY+2.8pp
QoQ-0.7pp
5Y change+1.4pp
10Y change+2.9pp

CTS Corporation's operating margin was 15.8% in Q1 2026, reflecting core business profitability. This is up 2.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.7 percentage points.

Net Margin
12.3%
YoY+1.7pp
QoQ-2.0pp
5Y change+3.0pp
10Y change+4.2pp

CTS Corporation's net profit margin was 12.3% in Q1 2026, showing the share of revenue converted to profit. This is up 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.0 percentage points.

Return on Equity
3.1%
YoY+0.6pp
QoQ-0.5pp
5Y change+0.3pp
10Y change+0.3pp

CTS Corporation's ROE was 3.1% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is up 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.5 percentage points.

Capital Allocation

R&D Spending
$6.6M
YoY+7.2%
QoQ+13.4%
5Y CAGR+3.1%

CTS Corporation invested $6.6M in research and development in Q1 2026. This represents an increase of 7.2% from the same quarter a year earlier. Against the prior quarter it is up 13.4%.

Share Buybacks
$8.6M
YoY+32.4%
QoQ-48.5%

CTS Corporation spent $8.6M on share buybacks in Q1 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 32.4% from the same quarter a year earlier. Against the prior quarter it is down 48.5%.

Capital Expenditures
$5.0M
YoY+11.9%
QoQ+56.7%
5Y CAGR+25.0%
10Y CAGR+5.7%

CTS Corporation invested $5.0M in capex in Q1 2026, funding long-term assets and infrastructure. This represents an increase of 11.9% from the same quarter a year earlier. Against the prior quarter it is up 56.7%.

CTS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CTS quarterly income statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Revenue$139.2M+10.7%$137.3M+8.5%$143.0M+8.0%$135.3M+4.0%$125.8M0.0%$126.5M+1.4%$132.4M-1.6%$130.2M-10.3%
Cost of Revenue$84.2M+6.3%$83.6M+5.0%$87.6M+5.3%$82.9M-1.1%$79.2M-1.8%$79.6M-3.7%$83.2M-5.6%$83.8M-11.3%
Gross Profit$55.0M+18.1%$53.7M+14.5%$55.3M+12.5%$52.4M+13.1%$46.5M+3.2%$46.9M+11.5%$49.2M+6.0%$46.4M-8.6%
R&D Expenses$6.6M+7.2%$5.9M+3.2%$6.9M+37.2%$6.3M+3.9%$6.2M-6.2%$5.7M+7.2%$5.0M-20.4%$6.1M-9.4%
SG&A Expenses$26.0M+10.0%$24.8M+11.8%$27.2M+20.9%$23.1M+8.2%$23.6M+6.1%$22.2M+13.9%$22.5M+20.6%$21.3M-10.0%
Operating Income$22.0M+35.0%$22.7M+26.0%$20.9M+0.3%$22.7M+28.0%$16.3M+12.0%$18.0M+10.8%$20.9M+14.8%$17.8M-3.6%
EBITDA$30.8M+24.3%$31.3M+19.2%$29.8M+3.1%$31.3M+24.7%$24.8M+13.3%$26.3M+11.7%$28.9M+13.5%$25.1M-2.3%
Interest Expense$708K-39.3%$911K-29.7%$1.1M-15.1%$1.1M+34.6%$1.2M+45.7%$1.3M+57.5%$1.3M+31.1%$833K+1.8%
Income Tax$4.5M+62.5%$5.2M+39.2%$6.0M+60.3%$4.5M+45.5%$2.8M+8.5%$3.7M+62.3%$3.8M-21.0%$3.1M-3.8%
Net Income$17.2M+28.7%$19.7M+70.7%$13.7M-24.3%$18.5M+26.0%$13.4M+20.2%$11.6M-24.5%$18.1M+29.4%$14.7M+14.0%
EPS (Basic)$0.60+33.3%$0.68+78.9%$0.47-21.7%$0.62+29.2%$0.45+25.0%$0.38-22.4%$0.60+33.3%$0.48+17.1%
EPS (Diluted)$0.59+34.1%$0.67+76.3%$0.46-22.0%$0.62+29.2%$0.44+22.2%$0.38-22.4%$0.59+34.1%$0.48+17.1%
Diluted Shares (Avg)29M-4.4%N/A30M-3.0%30M-2.4%30M-2.2%N/A31M-3.1%31M-3.0%

CTS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CTS quarterly balance sheet
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Total Assets$777.2M+1.5%$764.3M-0.1%$790.4M+0.1%$784.7M+8.1%$765.5M+4.5%$765.4M+3.3%$789.6M+4.7%$725.6M-4.0%
Current Assets$266.0M+9.2%$252.7M+4.3%$276.2M+8.6%$261.8M-16.9%$243.5M-23.5%$242.2M-24.2%$254.3M-23.9%$314.9M-4.6%
Cash & Equivalents$90.9M+0.6%$82.3M-12.8%$110.3M+16.3%$99.4M-38.3%$90.3M-44.4%$94.3M-42.4%$94.9M-40.7%$161.2M+6.9%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$57.3M+6.3%$52.9M+1.0%$54.2M-3.2%$57.1M+10.5%$53.9M-6.8%$52.3M-12.9%$56.0M-14.3%$51.7M-17.4%
Accounts Receivable$93.8M+15.1%$88.1M+13.5%$85.9M-0.6%$85.6M+0.2%$81.4M+1.0%$77.6M-1.2%$86.4M-3.6%$85.4M-12.4%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$208.7M+2.6%$209.6M+4.1%$207.3M+5.6%$207.5M+33.0%$203.4M+30.1%$201.3M+27.7%$196.2M+27.3%$156.1M+0.1%
Total Liabilities$219.7M-3.3%$212.5M-10.4%$242.7M-6.4%$234.6M+15.6%$227.3M+7.4%$237.2M+10.7%$259.4M+12.1%$202.9M-13.5%
Current Liabilities$105.4M+14.0%$109.7M+11.4%$104.8M+0.2%$100.5M+8.7%$92.4M-3.7%$98.5M+1.5%$104.6M+1.1%$92.4M-13.7%
Non-Current Liabilities$114.3M-15.3%$102.8M-25.9%$137.9M-10.9%$134.1M+21.4%$134.9M+16.7%$138.8M+18.3%$154.8M+21.1%$110.4M-13.3%
Total Equity$557.5M+3.6%$551.8M+4.5%$547.7M+3.3%$550.2M+5.2%$538.2M+3.3%$528.2M+0.3%$530.2M+1.4%$522.8M+0.3%
Retained Earnings$729.5M+9.7%$713.5M+9.3%$694.9M+8.2%$682.4M+9.1%$665.0M+8.6%$652.9M+8.4%$642.5M+9.2%$625.6M+8.7%

Not reported in any period shown, so not listed: Long-Term Debt.

CTS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CTS quarterly cash flow statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Operating Cash Flow$17.3M+11.5%$29.2M+17.3%$29.0M-18.0%$28.4M+44.4%$15.5M-15.3%$24.9M-22.3%$35.4M+59.9%$19.6M-16.2%
Depreciation & Amortization$8.8M+3.7%$8.7M+4.6%$8.8M+10.5%$8.6M+16.8%$8.5M+16.0%$8.3M+13.6%$8.0M+10.2%$7.3M+0.9%
Capital Expenditures$5.0M+11.9%$3.2M-47.7%$4.8M+23.9%$3.3M-29.3%$4.5M+10.7%$6.1M+74.2%$3.9M+40.8%$4.6M+17.5%
Free Cash Flow$12.3M+11.3%$26.0M+38.4%$24.2M-23.2%$25.1M+67.2%$11.1M-22.6%$18.8M-34.2%$31.5M+62.6%$15.0M-23.0%
Investing Cash Flow-$2.1M+52.8%-$6.0M+2.1%-$4.8M+96.2%-$3.3M+29.3%-$4.5M-10.7%-$6.1M-74.2%-$125.8M-4475.6%-$4.6M-17.4%
Financing Cash Flow-$6.4M+59.5%-$51.0M-163.1%-$15.1M-161.3%-$16.5M-4.4%-$15.9M+2.5%-$19.4M+23.8%$24.6M+346.4%-$15.8M-18.1%
Dividends Paid$1.2M-4.2%$1.2M-3.4%$1.2M-3.6%$1.2M-2.7%$1.2M-2.6%$1.2M-3.2%$1.2M-3.2%$1.2M-3.6%
Share Buybacks$8.6M+32.4%$16.6M+113.0%$16.6M+39.1%$16.5M+51.2%$6.5M-45.9%$7.8M-48.1%$11.9M+42.8%$10.9M+24.8%

Not reported in any period shown, so not listed: Stock-Based Compensation.

CTS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CTS quarterly financial ratios
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Gross Margin39.5%+2.5pp39.1%+2.0pp38.7%+1.6pp38.8%+3.1pp37.0%+1.2pp37.1%+3.4pp37.2%+2.7pp35.6%+0.7pp
Operating Margin15.8%+2.8pp16.5%+2.3pp14.6%-1.1pp16.8%+3.1pp13.0%+1.4pp14.2%+1.2pp15.8%+2.3pp13.7%+1.0pp
Net Margin12.3%+1.7pp14.4%+5.2pp9.6%-4.1pp13.7%+2.4pp10.6%+1.8pp9.1%-3.1pp13.7%+3.3pp11.3%+2.4pp
Return on Equity3.1%+0.6pp3.6%+1.4pp2.5%-0.9pp3.4%+0.6pp2.5%+0.3pp2.2%-0.7pp3.4%+0.7pp2.8%+0.3pp
Return on Assets2.2%+0.5pp2.6%+1.1pp1.7%-0.6pp2.4%+0.3pp1.8%+0.2pp1.5%-0.6pp2.3%+0.4pp2.0%+0.3pp
Current Ratio2.52-0.1x2.30-0.2x2.64+0.2x2.61-0.8x2.63-0.7x2.46-0.8x2.43-0.8x3.41+0.3x
Debt-to-Equity0.390.0x0.39-0.1x0.440.0x0.430.0x0.420.0x0.450.0x0.490.0x0.39-0.1x
Asset Turnover0.180.0x0.180.0x0.180.0x0.170.0x0.160.0x0.170.0x0.170.0x0.180.0x
FCF Margin8.8%0.0pp19.0%+4.1pp16.9%-6.9pp18.5%+7.0pp8.8%-2.6pp14.9%-8.0pp23.8%+9.4pp11.5%-1.9pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
CTS Corporation CTS FY2025 $541.3M $65.3M 12.1% $1.6B 67/100
Benchmark Electronics BHE FY2025 $2.7B $24.9M 0.9% $2.9B 56/100
Rogers Corporation ROG FY2025 $810.8M -$61.8M -7.6% $2.6B 51/100
Daktronics Inc DAKT FY2026 $838.7M $45.4M 5.4% $866.1M 63/100
Allient Inc. ALNT FY2025 $554.5M $22.0M 4.0% $1.9B 55/100
Bel Fuse Inc BELFB FY2025 $675.5M $74.1M 11.0% $3.5B 64/100

Frequently Asked Questions

What is CTS Corporation's annual revenue?

CTS Corporation (CTS) reported $541.3M in total revenue for fiscal year 2025. This represents a 5.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CTS Corporation's revenue growing?

CTS Corporation (CTS) revenue grew by 5.2% year-over-year, from $514.8M to $541.3M in fiscal year 2025.

Is CTS Corporation profitable?

Yes, CTS Corporation (CTS) reported a net income of $65.3M in fiscal year 2025, with a net profit margin of 12.1%.

CTS Corporation (CTS) reported diluted earnings per share of $2.19 for fiscal year 2025. This represents a 21.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CTS Corporation (CTS) had EBITDA of $117.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

CTS Corporation (CTS) had a gross margin of 38.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

CTS Corporation (CTS) had an operating margin of 15.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

CTS Corporation (CTS) had a net profit margin of 12.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, CTS Corporation (CTS) paid $0.16 per share in dividends during fiscal year 2025.

CTS Corporation (CTS) has a return on equity of 11.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

CTS Corporation (CTS) generated $86.4M in free cash flow during fiscal year 2025. This represents a 8.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

CTS Corporation (CTS) generated $102.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

CTS Corporation (CTS) had $764.3M in total assets as of fiscal year 2025, including both current and long-term assets.

CTS Corporation (CTS) invested $15.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

CTS Corporation (CTS) invested $25.3M in research and development during fiscal year 2025.

Yes, CTS Corporation (CTS) spent $56.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

CTS Corporation (CTS) had 29M shares outstanding as of fiscal year 2025.

CTS Corporation (CTS) had a current ratio of 2.30 as of fiscal year 2025, which is generally considered healthy.

CTS Corporation (CTS) had a debt-to-equity ratio of 0.39 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

CTS Corporation (CTS) had a return on assets of 8.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

CTS Corporation (CTS) trades at 23.6x earnings, its market capitalization divided by net income of $69.1M net income, trailing 12 months to March 31, 2026. The market capitalization is $1.6B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

CTS Corporation (CTS) trades at 2.9x sales, its market capitalization divided by revenue of $554.8M revenue, trailing 12 months to March 31, 2026. The market capitalization is $1.6B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

CTS Corporation (CTS) has an Altman Z-Score of 7.21, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

CTS Corporation (CTS) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

CTS Corporation (CTS) has an earnings quality ratio of 1.56x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

CTS Corporation (CTS) has an interest coverage ratio of 19.18x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

CTS Corporation (CTS) scores 67 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top